Management
Seek expert advice.
Management of small intestinal bacterial overgrowth (SIBO) generally involves:
- eradication of bacterial overgrowth with antimicrobial therapy (often requiring repeated courses)
- correction of associated nutritional deficiencies
- identification and correction of the underlying predisposing condition, where possible
Antimicrobial therapy:
- antibiotics used include metronidazole, ciprofloxacin, tetracycline, amoxicillin-clavulanate, neomycin, and rifaximin, with rifaximin being the most extensively investigated (1)
- hydrogen-predominant bacterial overgrowth:
- rifaximin 1650 mg/day for 2 weeks is an effective regimen (1)
- methane-predominant bacterial overgrowth:
- combining neomycin 1000 mg/day and rifaximin 1650 mg/day for 2 weeks is an effective regimen (2)
Recurrence:
- approximately 45% of patients experience recurrent SIBO following completion of antibiotic therapy (3)
- higher recurrence rates are associated with:
- older age
- history of appendicectomy
- chronic use of proton pump inhibitors (3)
Nutritional support:
- associated vitamin and mineral deficiencies (including vitamin B12, iron, thiamine, niacin, and fat-soluble vitamins) should be identified and corrected accordingly
Reference:
- Shah SC, Day LW, Somsouk M, Sewell JL. Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth. Aliment Pharmacol Ther. 2013 Oct;38(8):925-34.
- Pimentel M, Chang C, Chua KS, Mirocha J, DiBaise J, Rao S, Amichai M. Antibiotic treatment of constipation-predominant irritable bowel syndrome. Dig Dis Sci. 2014 Jun;59(6):1278-85.
- Lauritano EC et al. Small intestinal bacterial overgrowth recurrence after antibiotic therapy. Am J Gastroenterol. 2008 Aug;103(8):2031-5.
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.